NRXP
NRX Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
NRXP Filings
Filing Date
Form Description
Form Type
2025-12-23
Form EFFECT - Notice of Effectiveness
2025-12-23 ·
Form EFFECT - Notice of Effectiveness
2025-12-22
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-22 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-12
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-12-12 ·
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-11-26
Form 8-K - Current report
Key Events
2025-11-26 · Key Events
Form 8-K - Current report
2025-11-21
Form 8-K/A - Current report: [Amend]
Key Events
2025-11-21 · Key Events
Form 8-K/A - Current report: [Amend]
2025-11-17
NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-17 · Earnings Call
NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-23
Form 8-K - Current report
Key Events
2025-10-23 · Key Events
Form 8-K - Current report
2025-09-26
Form 8-K - Current report
Key Events
2025-09-26 · Key Events
Form 8-K - Current report
2025-09-12
Form 8-K - Current report
Key Events
2025-09-12 · Key Events
Form 8-K - Current report
